These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 35201615)

  • 21. Using provider-parent strategies to improve influenza vaccination in children and adolescents with special risk medical conditions: a randomised controlled trial protocol.
    Tuckerman J; Harper K; Sullivan TR; Fereday J; Couper J; Smith N; Tai A; Kelly A; Couper R; Friswell M; Flood L; Danchin M; Blyth CC; Marshall H
    BMJ Open; 2022 Feb; 12(2):e053838. PubMed ID: 35144952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021.
    Gargano JW; Wallace M; Hadler SC; Langley G; Su JR; Oster ME; Broder KR; Gee J; Weintraub E; Shimabukuro T; Scobie HM; Moulia D; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2021 Jul; 70(27):977-982. PubMed ID: 34237049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COVID-19 vaccination in children: a public health priority.
    da Fonseca Lima EJ; Leite RD
    J Pediatr (Rio J); 2023; 99 Suppl 1(Suppl 1):S28-S36. PubMed ID: 36564007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2006-2010.
    Naidu L; Chiu C; Habig A; Lowbridge C; Jayasinghe S; Wang H; McIntyre P; Menzies R
    Commun Dis Intell Q Rep; 2013 Dec; 37 Suppl():S1-95. PubMed ID: 24410428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modelling direct and herd protection effects of vaccination against the SARS-CoV-2 Delta variant in Australia.
    McBryde ES; Meehan MT; Caldwell JM; Adekunle AI; Ogunlade ST; Kuddus MA; Ragonnet R; Jayasundara P; Trauer JM; Cope RC
    Med J Aust; 2021 Nov; 215(9):427-432. PubMed ID: 34477236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
    Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5-11 Years - United States, November 2021.
    Woodworth KR; Moulia D; Collins JP; Hadler SC; Jones JM; Reddy SC; Chamberland M; Campos-Outcalt D; Morgan RL; Brooks O; Talbot HK; Lee GM; Bell BP; Daley MF; Mbaeyi S; Dooling K; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2021 Nov; 70(45):1579-1583. PubMed ID: 34758012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pediatric hematology/oncology physician and nurse practitioner attitudes towards the COVID-19 vaccines: A qualitative study.
    Miller ME; Rahim MQ; Coven SL; Jacob SA; Zimet GD; Meagher CG; Ott MA
    Hum Vaccin Immunother; 2022 Nov; 18(5):2048560. PubMed ID: 35344683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC).
    Wharton M; Strikas RA; Harpaz R; Rotz LD; Schwartz B; Casey CG; Pearson ML; Anderson LJ; ;
    MMWR Recomm Rep; 2003 Apr; 52(RR-7):1-16. PubMed ID: 12710832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Confident and altruistic - parents' motives to vaccinate their children against COVID-19: a cross-sectional online survey in a Swiss vaccination centre.
    Wagner A; Liberatore F; Schmelzer S; Dratva J
    Swiss Med Wkly; 2022 Mar; 152():w30156. PubMed ID: 35315342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medical Oncology Group of Australia position statement: COVID-19 vaccination in patients with solid tumours.
    Kanjanapan Y; Blinman P; Underhill C; Karikios D; Segelov E; Yip D
    Intern Med J; 2021 Jun; 51(6):955-959. PubMed ID: 34155756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.
    Maneikis K; Šablauskas K; Ringelevičiūtė U; Vaitekėnaitė V; Čekauskienė R; Kryžauskaitė L; Naumovas D; Banys V; Pečeliūnas V; Beinortas T; Griškevičius L
    Lancet Haematol; 2021 Aug; 8(8):e583-e592. PubMed ID: 34224668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel drive-through approach to vaccination of children and young people with neurodevelopmental disability.
    Keen M; Wen S; Heussler H; Tracey J; Nasser C; Doyle R
    J Paediatr Child Health; 2024 Jun; 60(6):164-167. PubMed ID: 38860667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety Monitoring of an Additional Dose of COVID-19 Vaccine - United States, August 12-September 19, 2021.
    Hause AM; Baggs J; Gee J; Marquez P; Myers TR; Shimabukuro TT; Shay DK
    MMWR Morb Mortal Wkly Rep; 2021 Oct; 70(39):1379-1384. PubMed ID: 34591835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How compassionate use enabled Israel to deliver the Pfizer-BioNTech COVID-19 vaccination to vulnerable children aged 12-15 years before regulatory approval.
    Stein M; Grossman Z; Brosh-Nissimov T; Gottesman BS; Shahar A; Wechsler E; Matz E; Cohen O; Alroy-Preis S; Anis E;
    Acta Paediatr; 2022 Apr; 111(4):834-841. PubMed ID: 34931371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COVID-19 Vaccination in Cancer Patients: A Review Article.
    Mekkawi R; Elkattan BA; Shablak A; Bakr M; Yassin MA; Omar NE
    Cancer Control; 2022; 29():10732748221106266. PubMed ID: 36066031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and immunogenicity of COVID-19 vaccination in immunocompromised patients.
    Song JW; Hu W; Shen L; Wang FS
    Chin Med J (Engl); 2022 Nov; 135(22):2656-2666. PubMed ID: 36719354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Considerations for vaccinating children against COVID-19.
    Hart JD; Ong DS; Chokephaibulkit K; Ong-Lim AT; Vereti I; Crawford NW; Russell F
    BMJ Paediatr Open; 2023 Jul; 7(1):. PubMed ID: 37487674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COVID-19 vaccine use in immunocompromised patients: A commentary on evidence and recommendations.
    Duly K; Farraye FA; Bhat S
    Am J Health Syst Pharm; 2022 Jan; 79(2):63-71. PubMed ID: 34455440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.